cyclosporine has been researched along with Shock, Septic in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bach, JF; Evans, NA; Manchester, AC; Walker, JM | 1 |
| Asano, J; Shinzato, I; Takafuta, T; Tanaka, Y; Ueda, R | 1 |
| Dinges, MM; Gregerson, DS; McCormick, JK; Schlievert, PM; Tripp, TJ | 1 |
| Iwamura, H; Sato, M; Wakitani, K | 1 |
| Britt, LD; Obias, VJ; Prewitt, RL; Rice, D; Rushing, GD | 1 |
| Benoit, JM; Bouaboula, M; Bourrie, B; Casellas, P; Derocq, JM; Esclangon, M; Le Fur, G | 1 |
| Heeg, K; Miethke, T; Wagner, H; Wahl, C | 1 |
| Bluethmann, H; Bonventre, PF; Cullen, CM; Edwards, CK; Heeg, H; Mountz, JD | 1 |
| Bendigs, S; Blank, C; Erdmann, A; Heeg, K; Luz, A; Wagner, H | 1 |
| Bradford, B; Enomoto, N; Ikejema, K; Rose, ML; Rusyn, I; Schemmer, P; Seabra, V; Stacklewitz, RF; Thurman, RG; Wheeler, MD; Yin, M; Zhong, Z | 1 |
1 review(s) available for cyclosporine and Shock, Septic
| Article | Year |
|---|---|
Glycine: a new anti-inflammatory immunonutrient.
Topics: Alcohols; Animals; Anti-Inflammatory Agents; Calcium Channels, L-Type; Chloride Channels; Cyclosporine; Free Radicals; Glycine; Hepatitis, Alcoholic; Humans; Hypoxia; Inflammation; Kupffer Cells; Leukocytes; Melanoma; Reperfusion Injury; Shock, Septic; Taurine | 1999 |
9 other study(ies) available for cyclosporine and Shock, Septic
| Article | Year |
|---|---|
Acute respiratory distress syndrome and septic shock in a cat with disseminated toxoplasmosis.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clindamycin; Cyclosporine; Fatal Outcome; Immunocompromised Host; Immunosuppressive Agents; Lung Diseases, Parasitic; Male; Oxygen; Respiratory Distress Syndrome; Shock, Septic; Toxoplasmosis, Animal | 2017 |
Effects of immunosuppressive therapy in a patient with aplastic anemia-paroxysmal nocturnal hemoglobinuria (AA-PNH) syndrome during ongoing eculizumab treatment.
Topics: Aged; Anemia, Aplastic; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Bacteremia; Blood Transfusion; Combined Modality Therapy; Complement Inactivating Agents; Cyclosporine; Escherichia coli Infections; Female; Granulocyte Colony-Stimulating Factor; Hemoglobinuria, Paroxysmal; Hemolysis; Humans; Immunosuppressive Agents; Lenograstim; Recombinant Proteins; Shock, Septic; T-Lymphocytes; Urinary Tract Infections | 2014 |
Effects of total body irradiation and cyclosporin a on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome.
Topics: Animals; Bacterial Toxins; Cyclosporine; Enterotoxins; Female; Immunosuppression Therapy; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Rabbits; Shock, Septic; Staphylococcal Infections; Staphylococcus aureus; Superantigens; T-Lymphocytes; Whole-Body Irradiation | 2003 |
Comparative study of glucocorticoids, cyclosporine A, and JTE-607 [(-)-Ethyl-N[3,5-dichloro-2-hydroxy-4-[2-(4-methylpiperazin-1-yl)ethoxy]benzoyl]-L-phenylalaninate dihydrochloride] in a mouse septic shock model.
Topics: Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cyclosporine; Cytokines; Enzyme-Linked Immunosorbent Assay; Glucocorticoids; Immunosuppressive Agents; Leukocyte Count; Lung; Male; Mice; Mice, Inbred BALB C; Peroxidase; Phenylalanine; Piperazines; Platelet Count; Prednisolone; Shock, Septic | 2004 |
Cyclosporine inhibits endotoxin-induced vasodilation of isolated rat resistance arterioles.
Topics: Animals; Aorta; Arterioles; Cyclosporine; Endotoxemia; Immunosuppressive Agents; In Vitro Techniques; Male; NF-kappa B; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Shock, Septic; Vascular Resistance; Vasodilation | 2006 |
Enhancement of endotoxin-induced interleukin-10 production by SR 31747A, a sigma ligand.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Base Sequence; Cyclohexanes; Cyclosporine; Dexamethasone; DNA, Complementary; Female; Galactosamine; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Lipopolysaccharides; Lymphocyte Subsets; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, SCID; Molecular Sequence Data; Polymerase Chain Reaction; Receptors, sigma; RNA, Messenger; Shock, Septic; Tumor Necrosis Factor-alpha | 1995 |
Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
Topics: Animals; Antigens, Bacterial; Bacterial Toxins; Cyclosporine; Enterotoxins; Galactosamine; Immunity, Innate; Interleukin-2; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Interleukin-2; Shock, Septic; Staphylococcus aureus; Superantigens; T-Lymphocytes | 1993 |
A fas antigen receptor mutation allows development of toxic shock syndrome toxin-1-induced lethal shock in V beta 8.2 T-cell receptor transgenic mice.
Topics: Adenine; Animals; Bacterial Toxins; Base Sequence; Cells, Cultured; Cyclosporine; Enterotoxins; fas Receptor; Female; Heterozygote; Interleukin-2; Interleukin-6; Isoquinolines; Lipopolysaccharides; Liver; Lymphocyte Activation; Mice; Mice, Transgenic; Molecular Sequence Data; Mutation; Nitrogen Oxides; Receptors, Antigen, T-Cell, alpha-beta; Recombinant Proteins; Shock, Septic; Spleen; Superantigens; Tumor Necrosis Factor-alpha | 1995 |
Superantigen and endotoxin synergize in the induction of lethal shock.
Topics: Animals; Antibodies, Blocking; Antibodies, Monoclonal; Clonal Anergy; Clonal Deletion; Cyclosporine; Cytokines; Drug Synergism; Enterotoxins; Female; Galactosamine; Injections, Intravenous; Interferon-gamma; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Receptors, Antigen, T-Cell, alpha-beta; Shock, Septic; Staphylococcus aureus; Superantigens; T-Lymphocyte Subsets | 1997 |